Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
- Author:
Jihye PARK
1
;
Jae Hee CHEON
Author Information
- Publication Type:Editorial
- From:Gut and Liver 2021;15(5):641-642
- CountryRepublic of Korea
- Language:English
